MetLife Investment Management LLC raised its holdings in REX American Resources Co. (NYSE:REX – Get Rating) by 200.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,181 shares of the energy company’s stock after buying an additional 5,454 shares during the quarter. […]
Axa S.A. increased its position in REX American Resources Co. (NYSE:REX – Get Rating) by 200.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,625 shares of the energy company’s stock after buying an additional 13,750 shares during the […]
Comerica Bank grew its holdings in REX American Resources Co. (NYSE:REX - Get Rating) by 170.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,941 shares of the energy company's stock after acquiring an additional 7
Several analysts have recently updated their ratings and price targets for REX American Resources (NYSE: REX): 6/8/2022 – REX American Resources was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “strong-buy” rating. They now have a $104.00 price target on the stock. According to Zacks, “REX American Resources Corporation, formerly […]
Research Analysts’ downgrades for Tuesday, May 31st: Adverum Biotechnologies (NASDAQ:ADVM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable […]